Rac1 is involved in several cardiovascular pathologies, e.g., vascular smooth muscle proliferation, atherosclerosis cardiomyocyte hypertrophy and endothelial dysfunction in hypertension, and is considered a promising therapeutic target in cerebro- and cardiovascular diseases [54]. Here, RAC1 is linked to atherosclerosis.